Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their Caregivers.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 10 09 2024
revised: 10 10 2024
accepted: 12 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

(1) Background: Clinical aspects like sex, age, Karnofsky Performance Scale (KPS) and psychosocial distress can affect the health-related quality of life (HR-QoL) and treatment satisfaction of patients with malignant isocitrate dehydrogenase wild-type (IDHwt) gliomas and caregivers. (2) Methods: We prospectively investigated the HR-QoL and patient/caregiver treatment satisfaction in a cross-sectional study with univariable and multiple regression analyses. Questionnaires were applied to investigate the HR-QoL (EORTC QLQ-C30, QLQ-BN20) and treatment satisfaction (EORTC PATSAT-C33). (3) Results: A cohort of 61 patients was investigated. A higher KPS was significantly associated with a better HR-QoL regarding the functional scales of the EORTC QLQ-C30 (

Identifiants

pubmed: 39451763
pii: curroncol31100459
doi: 10.3390/curroncol31100459
doi:

Substances chimiques

Isocitrate Dehydrogenase EC 1.1.1.41

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6155-6170

Auteurs

Anna Fischl (A)

Department of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.

Michael Gerken (M)

Center for Quality Assurance and Health Services Research, University of Regensburg, 93053 Regensburg, Germany.

Patricia Lindberg-Scharf (P)

Center for Quality Assurance and Health Services Research, University of Regensburg, 93053 Regensburg, Germany.

Tareq M Haedenkamp (TM)

Department of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.

Katharina Rosengarth (K)

Department of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.

Andrea Hillberg (A)

Department of Internal Medicine III, Regensburg University Hospital, 93053 Regensburg, Germany.

Martin Vogelhuber (M)

Department of Internal Medicine III, Regensburg University Hospital, 93053 Regensburg, Germany.

Ingrid Schön (I)

Department of Internal Medicine III, Regensburg University Hospital, 93053 Regensburg, Germany.

Martin Proescholdt (M)

Department of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.

Tommaso Araceli (T)

Department of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.

Michael Koller (M)

Center for Clinical Trials, Regensburg University Hospital, 93053 Regensburg, Germany.

Anne Herrmann (A)

Department of Epidemiology and Preventive Medicine/Medical Sociology, University of Regensburg, 93053 Regensburg, Germany.

Oliver Kölbl (O)

Department of Radiotherapy, Regensburg University Hospital, 93053 Regensburg, Germany.

Tobias Pukrop (T)

Department of Internal Medicine III, Regensburg University Hospital, 93053 Regensburg, Germany.

Markus J Riemenschneider (MJ)

Department of Neuropathology, Regensburg University Hospital, 93053 Regensburg, Germany.

Nils Ole Schmidt (NO)

Department of Neurosurgery, Regensburg University Hospital, 93053 Regensburg, Germany.

Monika Klinkhammer-Schalke (M)

Center for Quality Assurance and Health Services Research, University of Regensburg, 93053 Regensburg, Germany.

Ralf Linker (R)

Department of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.

Peter Hau (P)

Department of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.

Elisabeth Bumes (E)

Department of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH